Katkin Keith

Avg. Two Year Performance

88% Avg. Purchase Return
37% Compound
(4%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%13%27%19%88%
Purchase Success Rate2 of 32 of 32 of 32 of 32 of 3
Average Sale Return(3%)(7%)(2%)(6%)(4%)
Sale Success Rate5 of 185 of 185 of 184 of 183 of 18
Drugs » Drug Manufacturers - Other

President and CEO, Director:

Holdings: 914.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

PEO;CEO/Urovant Sciences, Inc., Director:

Holdings: 199.68K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: 25.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 42.44K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 65.0K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--